Please login to the form below

Not currently logged in
Email:
Password:

Nycomed

This page shows the latest Nycomed news and features for those working in and with pharma, biotech and healthcare.

Lundbeck challenge to EC pay-for-delay ruling fails

Lundbeck challenge to EC pay-for-delay ruling fails

Two other investigations - involving AstraZeneca/Nycomed and Teva/Cephalon - did not result in enforcement action by the Commission.

Latest news

More from news
Approximately 1 fully matching, plus 71 partially matching documents found.

Latest Intelligence

  • Forging a path in specialty care Forging a path in specialty care

    In recent years Takeda has joined in the industry's enthusiasm for mergers and acquisitions, notably of Millennium in Boston, Massachusetts and Nycomed headquartered in Zurich, Switzerland.

  • Pharma deals during May 2014 Pharma deals during May 2014

    in Europe, Meda (rejected bid from Mylan), AMco and previously Nycomed (now owned by Takeda). The companies funded by debt provided by private equity are usually sold so Allergan's questions

  • Pharma deals during October 2013 Pharma deals during October 2013

    licensing agreement it inherited through its acquisition of Nycomed.

  • Putin - pharma’s friend or foe in Russia? Putin - pharma’s friend or foe in Russia?

    For Nycomed the investment in Russia resulted in total sales in region of 640m in 2010. ... For Putin it had even larger implications - the success of Nycomed proved he was on to a winning strategy. .

  • Pharma deals during June 2013 Pharma deals during June 2013

    of its US patent expiration in January 2011. Nycomed had originally developed the drug, which it had licensed to Wyeth. Between them Teva and Sun Pharma will pay $2.15bn in

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....